Yunnan Baiyao (000538.SZ) stated on the investor platform that its aerosol sales revenue contributed more than 1.7 billion yuan, a year-on-year increase of 15.27%. Sales revenue of Yunnan Baiyao patches, Yunnan Baiyao ointment, Yunnan Baiyao (powder), and Yunnan Baiyao capsules all exceeded 100 million yuan. Yunnan Baiyao ointment had a sales revenue of over 0.9 billion yuan, Yunnan Baiyao capsules had a sales revenue of over 0.6 billion yuan, and Yunnan Baiyao (powder) and Yunnan Baiyao patches had a sales revenue of over 0.3 billion yuan. The function of Yunnan Baiyao aerosols is to promote blood circulation and relieve blood stasis, reduce swelling and alleviate pain. It is used for bruises, hematoma, muscle pain, and rheumatic pain. The function of Yunnan Baiyao liniment is to promote blood circulation and relieve blood stasis, reduce swelling and alleviate pain. It is used for bruises, numbness due to wind and cold, joint pain, muscle soreness, and frostbite. The function of Yunnan Baiyao ointment is to promote blood circulation, relieve blood stasis, reduce swelling, alleviate pain, and dispel wind and dampness. It is used for bruises, hematoma, rheumatic pain, and other related diseases.
云南白药(000538.SZ)：云南白药气雾剂销售收入贡献超过17亿元，同比增长15.27%
Yunnan Baiyao Group (000538.SZ): The sales revenue from Yunnan Baiyao aerosol contributed more than 1.7 billion yuan, with a year-on-year growth of 15.27%.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.